Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01485939
Other study ID # Laparo_cholecystectomy_lidotop
Secondary ID
Status Recruiting
Phase Phase 4
First received November 28, 2011
Last updated December 5, 2011
Start date November 2011
Est. completion date May 2012

Study information

Verified date December 2011
Source Seoul National University Hospital
Contact Eunjoo Choi, MD
Phone 82-31-787-6572
Email ejchoi7956@gmail.com
Is FDA regulated No
Health authority Korea: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The investigators hypothesized that application of a 5% lidocaine patch would be associated with reduced pain scores after operation compared with placebo patch in patients undergoing laparoscopic cholecystectomy.


Description:

- The 5% lidocaine patch have been approved for the treatment of postherpetic neuralgia.

- The investigators hypothesized that application of a 5% lidocaine patch would be associated with reduced pain scores, pain controlled drug(opioids, NSAID) in post operative period.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date May 2012
Est. primary completion date March 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- patients of ASA ?-?

- aged 18~65

- scheduled to undergo elective laparoscopic cholecystectomy under general anesthesia.

Exclusion Criteria:

- patients with chronic pain

- patients with taking regular analgesics

- patients with allergy to ketorolac or lidocaine

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Other:
placebo patch applied
Patients in this group would applied the placebo patch after laparoscopic cholecystectomy.
5% lidocaine patch
Patients in this group would applied the 5% lidocaine patch after laparoscopic cholecystectomy.

Locations

Country Name City State
Korea, Republic of Seoul national university Bundang hospital Seongnam Kyoung-ki-do

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary post operative pain after laparoscopic cholecystectomy We will measure intensity of pain(numeric rating scale)at post operative 30 minutes, 1, 2, 4, 6, 12, 24, 48 hours. post operative periods No
Secondary pain controlled drug doses in postoperative periods. We will measure doses of pain controlled drug(opioid, NSAIDS) at post operative 30 minutes, 1, 2, 4, 6, 12, 24, 48 hours. postoperative periods No